QuidelOrtho
QDEL
#3543
Rank
S$4.08 B
Marketcap
$60.76
Share price
4.21%
Change (1 day)
-37.91%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

QuidelOrtho (QDEL) - P/B ratio

P/B ratio as of December 2024 : 0.9630

According to QuidelOrtho's latest financial reports the company has a price-to-book ratio of 1.08916.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

QuidelOrtho - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-310.8727-11.29%
2023-12-310.9837-14.2%
2022-12-311.15-60.69%
2021-12-312.92-48.57%
2020-12-315.671.06%
2019-12-315.6124.2%
2018-12-314.52-30.38%
2017-12-316.4986.2%
2016-12-313.497.88%
2015-12-313.23-20.51%
2014-12-314.06-13.59%
2013-12-314.7050.45%
2012-12-313.1315.2%
2011-12-312.71-25.89%
2010-12-313.6615.76%
2009-12-313.16-11.34%
2008-12-313.57-39.66%
2007-12-315.9133.71%
2006-12-314.425.75%
2005-12-314.18133.08%
2004-12-311.79-50.82%
2003-12-313.65128.41%
2002-12-311.60

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
4.05 320.03%๐Ÿ‡บ๐Ÿ‡ธ USA
2.55 164.45%๐Ÿ‡บ๐Ÿ‡ธ USA
4.08 323.45%๐Ÿ‡บ๐Ÿ‡ธ USA
0.6372-33.84%๐Ÿ‡บ๐Ÿ‡ธ USA
3.24 236.91%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80 86.84%๐Ÿ‡บ๐Ÿ‡ธ USA